HONG KONG – As part of a unique financing and potential acquisition deal, Pvp Biologics, of San Diego, will work with Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, to fund and speed up the development of a new enzyme that can minimize the negative impact of gluten on celiac disease patients.